Literature DB >> 21622281

Alternatively spliced tissue factor pathway inhibitor: functional implications.

Alan E Mast1.   

Abstract

Tissue factor pathway inhibitor (TFPI) is a factor Xa dependent inhibitor of tissue factor initiated blood coagulation. In recent years several alternatively spliced forms of TFPI have been identified. These alternatively spliced forms have different C-terminal regions and have different mechanisms for association with cell surfaces. They are differentially expressed in human and mouse tissues and may have distinct physiological functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622281      PMCID: PMC3549618          DOI: 10.2741/236

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  30 in total

1.  Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.

Authors:  Orlando Piro; George J Broze
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

2.  Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.

Authors:  W F Novotny; M Palmier; T C Wun; G J Broze; J P Miletich
Journal:  Blood       Date:  1991-07-15       Impact factor: 22.113

3.  A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.

Authors:  Brian Pedersen; Todd Holscher; Yuichiro Sato; Rafal Pawlinski; Nigel Mackman
Journal:  Blood       Date:  2004-12-14       Impact factor: 22.113

4.  Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

Authors:  M S Bajaj; M N Kuppuswamy; H Saito; S G Spitzer; S P Bajaj
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor.

Authors:  Jing Zhang; Orlando Piro; Lan Lu; George J Broze
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

6.  Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures.

Authors:  Sabine Schirm; Xu Liu; Lori L Jennings; Paul Jedrzejewski; Yumin Dai; Stephen Hardy
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

7.  Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).

Authors:  P M Sandset; U Abildgaard; M L Larsen
Journal:  Thromb Res       Date:  1988-06-15       Impact factor: 3.944

8.  Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.

Authors:  T Hamamoto; M Yamamoto; O Nordfang; J G Petersen; D C Foster; W Kisiel
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

9.  Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.

Authors:  Anna C Cunningham; Karen A Hasty; Jan J Enghild; Alan E Mast
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

10.  Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans.

Authors:  S A Maroney; J P Ferrel; M L Collins; A E Mast
Journal:  J Thromb Haemost       Date:  2008-05-22       Impact factor: 5.824

View more
  2 in total

1.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

Review 2.  Regulation of vascular function on posttranscriptional level.

Authors:  Andreas Eisenreich
Journal:  Thrombosis       Date:  2013-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.